Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Gastric Cancer

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    January 2024
  1. LIU W, Chen X, Zhou Z, Chen Y, et al
    Reinforcement of the stapled duodenal stump during laparoscopic gastrectomy.
    Br J Surg. 2024;111:znad305.
    PubMed    



  2. Erratum to: Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae025.
    PubMed    


  3. SCHNEIDER MA, Kim J, Berlth F, Sugita Y, et al
    Defining benchmarks for total and distal gastrectomy: global multicentre analysis.
    Br J Surg. 2024;111:znad379.
    PubMed    


  4. LI ZY, Wei B, Zhou YB, Li TY, et al
    Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znad435.
    PubMed     Abstract available


    September 2023
  5. BAUSYS A, Luksta M, Anglickiene G, Maneikiene VV, et al
    Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: randomized clinical trial.
    Br J Surg. 2023 Sep 26:znad312. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  6. MARKAR SR, Guazzelli A, Taylor A, Jones LL, et al
    Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.
    Br J Surg. 2023 Jun 28:znad180. doi: 10.1093.
    PubMed    


  7. VAN DIEREN JM, van der Post RS, Bisseling TM
    Shifting perceptions on endoscopic surveillance and timing of prophylactic gastrectomy for hereditary diffuse gastric cancer.
    Br J Surg. 2023 Jun 24:znad192. doi: 10.1093.
    PubMed    


    March 2023
  8. BAXTER MA, Khan KS, Gall LS, Samuelson C, et al
    Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study.
    Br J Surg. 2023;110:456-461.
    PubMed     Abstract available


  9. PUCHER PH, Park MH, Cromwell DA, Crosby TC, et al
    Diagnosis and treatment for gastro-oesophageal cancer in England and Wales: analysis of the National Oesophago-Gastric Cancer Audit (NOGCA) database 2012-2020.
    Br J Surg. 2023 Mar 27:znad065. doi: 10.1093.
    PubMed     Abstract available


    February 2023
  10. PARK SH, Hyung WJ, Yang HK, Park YK, et al
    Standard follow-up after curative surgery for advanced gastric cancer: secondary analysis of a multicentre randomized clinical trial (KLASS-02).
    Br J Surg. 2023 Feb 1:znad002. doi: 10.1093.
    PubMed     Abstract available


    November 2022
  11. KUROKAWA Y, Doki Y, Mizusawa J, Yoshikawa T, et al
    Five-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001).
    Br J Surg. 2022 Nov 12. pii: 6825225. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  12. SILVA ANS, Saito Y, Yoshikawa T, Oshima T, et al
    Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:e106.
    PubMed    


  13. LIU K, Hu JK
    Comment on: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:e105.
    PubMed    


    July 2022
  14. LIU K, Zhang WH, Hu JK
    Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:e91.
    PubMed    


  15. RAHMAN SA, Underwood TJ
    Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:e92.
    PubMed    


    February 2022
  16. SILVA ANS, Saito Y, Yoshikawa T, Oshima T, et al
    Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:291-297.
    PubMed     Abstract available


  17. RAHMAN S, Thomas B, Maynard N, Park MH, et al
    Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
    Br J Surg. 2022;109:227-236.
    PubMed     Abstract available


    November 2021
  18. RAHMAN SA, Maynard N, Trudgill N, Crosby T, et al
    Prediction of long-term survival after gastrectomy using random survival forests.
    Br J Surg. 2021;108:1341-1350.
    PubMed     Abstract available


    October 2021
  19. CHMELO J, Phillips AW, Greystoke A, Bradshaw A, et al
    Comparison of the effects of FLOT and ECX chemotherapy for oesophagogastric adenocarcinoma on cardiopulmonary reserve.
    Br J Surg. 2021;108:e328-e329.
    PubMed    


    September 2021
  20. ZHENG-YAN L, Feng Q, Yan S, Ji-Peng L, et al
    Learning curve of robotic distal and total gastrectomy.
    Br J Surg. 2021;108:1126-1132.
    PubMed     Abstract available


  21. BONNOT PE, Lintis A, Mercier F, Benzerdjeb N, et al
    Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).
    Br J Surg. 2021 Sep 9. pii: 6366963. doi: 10.1093.
    PubMed     Abstract available


  22. PARK DJ, Kim YW, Yang HK, Ryu KW, et al
    Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial).
    Br J Surg. 2021 Sep 6. pii: 6364812. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  23. ALKHAFFAF B, Metryka A, Blazeby JM, Glenny AM, et al
    Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus.
    Br J Surg. 2021 Jun 24. pii: 6308782. doi: 10.1093.
    PubMed     Abstract available


  24. PHILLIPS AW, Griffin SM
    Three decades of oesophagogastric cancer care: now a curable disease.
    Br J Surg. 2021;108:595-597.
    PubMed    


    May 2021
  25. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2021;108:542-549.
    PubMed     Abstract available


    March 2021
  26. KOEMANS WJ, van der Kaaij RT, van Sandick JW
    Reply to Correspondence to "Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy (HIPEC): first results of the PERISCOPE I study".
    Br J Surg. 2021;108:e94.
    PubMed    


  27. CHIU CC, Lee PH, Chang CS, Rau KM, et al
    Correspondence to 'Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results'.
    Br J Surg. 2021;108:e93.
    PubMed    


    January 2021
  28. KAMARAJAH SK, Navidi M, Phillips AW
    Response to "Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer".
    Br J Surg. 2021 Jan 31. pii: 6124825. doi: 10.1093.
    PubMed    


  29. HU Q, Sun Y, Yang X
    Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2021 Jan 31. pii: 6124822. doi: 10.1093.
    PubMed    


    November 2020
  30. LIU Y, Yang T, Wei YW
    What is the difference between overall survival, recurrence-free survival and time-to-recurrence?
    Br J Surg. 2020;107:e634.
    PubMed    


    October 2020
  31. HUANG J, Yang B, Tan J, Zhou S, et al
    Gastric cancer nodal tumour-stroma ratios influence prognosis.
    Br J Surg. 2020 Oct 14. doi: 10.1002/bjs.12054.
    PubMed     Abstract available


  32. JESTIN HANNAN C, Linder G, Kung CH, Johansson J, et al
    Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Br J Surg. 2020;107:1500-1509.
    PubMed     Abstract available


  33. VAN DER KAAIJ RT, Wassenaar ECE, Koemans WJ, Sikorska K, et al
    Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
    Br J Surg. 2020;107:1520-1528.
    PubMed     Abstract available


    September 2020
  34. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2020 Sep 29. doi: 10.1002/bjs.11928.
    PubMed     Abstract available


    August 2020
  35. LIN JP, Zhao YJ, He QL, Hao HK, et al
    Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas.
    Br J Surg. 2020;107:1163-1170.
    PubMed     Abstract available


    February 2020
  36. LU J, Zhao YJ, Zhou Y, He Q, et al
    Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
    Br J Surg. 2020;107:248-257.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.